Staphylococcus aureus (S. aureus) is a common and virulent human pathogen causing
several serious illnesses including skin abscesses, wound infections, endocarditis …

Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining
momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) …

Mycobacteriophages show promise as therapeutic agents for non-tuberculous
mycobacterium infections. However, little is known about phage recognition of …

Mycobacterium abscessus is one of the common clinical non-tuberculous mycobacteria
(NTM) that can cause severe skin infection. 5-Aminolevulinic acid photodynamic therapy …

Abstract Background Mycobacterium abscessus (Mab) is considered as the most pathogenic
rapid-growing mycobacteria in humans, causing pulmonary and extra-pulmonary diseases …

Background Mycobacterium abscessus belongs to the largest group of mycobacteria, the
rapid-growing saprophytic mycobacteria, and is one of the most difficult-to-treat opportunistic …

Mycobacterium abscessus is an emerging and difficult-to-manage mycobacterial species
that exhibits smooth (S) or rough (R) morphotypes. Disruption of glycopeptidolipid (GPL) …

The incidence of infections due to nontuberculous mycobacteria (NTM) has increased
rapidly in recent years, surpassing tuberculosis in developed countries. Due to inherent …

Persistent bacterial lung infections in children lead to significant morbidity and mortality due
to antibiotic resistance. In this paper, we describe how phage therapy has shown …

Antimicrobial resistance is an increasing threat to human populations. The emergence of
multidrug-resistant “superbugs” in mycobacterial infections has further complicated the …